Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Nosocomial spontaneous bacterial peritonitis (SBP) is frequently caused by multi drug
resistant bacteria. Standard treatment of SBP could be ineffective. The aim of the study is
to compare daptomycin + meropenem vs ceftazidime in the treatment of nosocomial SBP.